Altered Neuroretinal Tissue in Childhood Cancer Survivors: Data From the German CVSS Study
Follow-ups are needed to evaluate if this might result in increased risk for neurodegenerative ophthalmic diseases, like glaucoma.
Authors
- Irene Schmidtmann (ORCID: https://orcid.org/0000-0001-8743-6752)
- Philipp S. Wild (ORCID: https://orcid.org/0000-0003-4413-9752)
- Thomas Muenzel (ORCID: https://orcid.org/0000-0001-5503-4150)
- Tarkan Jäger (ORCID: https://orcid.org/0000-0002-2390-0226)
- Manfred E. Beutel (ORCID: https://orcid.org/0000-0003-1743-0042)
- Hiltrud Merzenich (ORCID: https://orcid.org/0000-0002-7299-3764)
- Stefan Nickels (ORCID: https://orcid.org/0000-0003-0415-2354)
- Karl J. Lackner (ORCID: https://orcid.org/0000-0002-1985-7931)
- Andreas Schulz (ORCID: https://orcid.org/0000-0003-1394-680X)
- Norbert Pfeiffer
- Alexander K. Schuster
- Jörg Faber
- Anna Maria Welzel
Institutions
- Johannes Gutenberg University Mainz (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- German Centre for Cardiovascular Research (DE)
- Institute of Molecular Biology (DE)
Publication Details
- Journal
- Translational Vision Science & Technology
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1167/tvst.14.10.33
- Primary Topic
- Childhood Cancer Survivors' Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- Pfizer
- Bayer
- Sanofi
- Deutsches Zentrum für Herz-Kreislaufforschung
- Deutsche Forschungsgemeinschaft
- Santen
- Stiftung Rheinland-Pfalz für Innovation
- Deutsche Ophthalmologische Gesellschaft
- Heidelberg Engineering
- Novartis Pharma
- Bayer Vital
- Daiichi Sankyo Europe